Subversive Capital's book
4 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Synchron | — | $385.0M | — | — | |
| Cambrian Bio | Drug Discovery | $180.0M | — | — | |
| Carver Edison | — | $109.0M | — | — | |
| AEXLAB | — | $108.0M | — | — |
Free account
See the whole book
- ·Watchlist + alerts for Subversive Capital's activity
Create free account
No card required